Home · APIs · Science and health · ClinicalTrials.gov search

ClinicalTrials.gov search API

One request, one key: POST /v1/science/clinicaltrials/search. The sample below is a real response captured 20 November 2026, shortened for display (long text cut, lists cut to three items); it is not invented.

Price

5 credits a call. One call is about $0.049 and 1,000 calls are about $49 at the smallest paid plan's rate.Formula A call that comes back empty is not charged.

Try it free

Runs one real call with the sample input below. No key and no sign-up; a few runs a day per visitor.

{
  "condition": "type 2 diabetes"
}

What it returns

FieldTypeValue in the sample
queryobject{"condition":"type 2 diabetes","intervention":"","status":"RECRUITING","phase":""}
total_matchingnumber0
returnednumber10
studieslist[{"nct_id":"NCT04783441","title":"Use of CGM in Kidney Transplant Recipients","status":"Recruiting","phase"...
sourcestringClinicalTrials.gov (official US government database)
search_urlstringhttps://clinicaltrials.gov/search?cond=type%202%20diabetes

Sample response (20 November 2026)

{
  "query": {
    "condition": "type 2 diabetes",
    "intervention": "",
    "status": "RECRUITING",
    "phase": ""
  },
  "total_matching": 0,
  "returned": 10,
  "studies": [
    {
      "nct_id": "NCT04783441",
      "title": "Use of CGM in Kidney Transplant Recipients",
      "status": "Recruiting",
      "phase": "N/A",
      "study_type": "INTERVENTIONAL",
      "conditions": [
        "Kidney Transplant; Complications",
        "Diabetes Mellitus, Type 2",
        "Insulin Dependent Diabetes"
      ],
      "lead_sponsor": "University of California, Davis",
      "enrollment": 80,
      "start_date": "2021-06-29",
      "completion_date": "2026-12-31",
      "brief_summary": "The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.",
      "primary_outcomes": [],
      "countries": [
        "United States"
      ],
      "clinicaltrials_url": "https://clinicaltrials.gov/study/NCT04783441",
      "eligibility_summary": "Inclusion Criteria:\n\n1. Age 18 or above\n2. Received a kidney transplant within the past year with functioning kidney (eGFR \\> 30 mL/min\n3. Person with Type 2 Diabetes and on insulin\n4. Access to home wi-fi connection\n\nExclusion Criteria:\n\n1. Person with Type 1 Diabetes\n2. Patients taking hydroxyurea"
    },
    {
      "nct_id": "NCT07017270",
      "title": "Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis",
      "status": "Recruiting",
      "phase": "Phase 4",
      "study_type": "INTERVENTIONAL",
      "conditions": [
        "Kidney Disease, Chronic",
        "Diabetes",
        "Dialysis"
      ],
      "lead_sponsor": "Unity Health Toronto",
      "enrollment": 100,
      "start_date": "2025-11-27",
      "completion_date": "2027-07",
      "brief_summary": "This study aims to determine if GLP1RA is safe and tolerable in maintenance dialysis population, adherence, and feasibility of a larger definitive cardiovascular outcome trial in this population. Participants will be randomized 1:1 to either weekly subcutaneous semaglutide versus usual care and foll...",
      "primary_outcomes": [],
      "countries": [
        "Canada"
      ],
      "clinicaltrials_url": "https://clinicaltrials.gov/study/NCT07017270",
      "eligibility_summary": "Inclusion Criteria:\n\n1. Age ≥ 18\n2. Receiving chronic maintenance hemodialysis or peritoneal dialysis for ≥ 90 days\n3. confirmed DM2 based on medical history and current or prior receipt of an oral hypoglycemic agent and/or insulin.\n4. Ability to provided informed consent or through their substitute"
    },
    {
      "nct_id": "NCT07664553",
      "title": "A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin",
      "status": "Recruiting",
      "phase": "Phase 3",
      "study_type": "INTERVENTIONAL",
      "conditions": [
        "Type 2 Diabetes Mellitus"
      ],
      "lead_sponsor": "AstraZeneca",
      "enrollment": 600,
      "start_date": "2026-07-08",
      "completion_date": "2028-05-23",
      "brief_summary": "The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with placebo in adults with Type 2 Diabetes Mellitus (T2DM), treated with a background insulin and other background glucose-lowering medication(s)",
      "primary_outcomes": [],
      "countries": [
        "India",
        "Malaysia",
        "China"
      ],
      "clinicaltrials_url": "https://clinicaltrials.gov/study/NCT07664553",
      "eligibility_summary": "Inclusion Criteria:\n\n* Diagnosed with T2DM for at least 90 days prior to screening\n* Stable treatment with background insulin and other background glucose-lowering medication(s)\n* HbA1c value of ≥ 7% to ≤ 10.5%\n* Body mass index (BMI) of ≥ 23 kg/m2 at screening\n* Stable body weight (self-reported or"
    }
  ],
  "source": "ClinicalTrials.gov (official US government database)",
  "search_url": "https://clinicaltrials.gov/search?cond=type%202%20diabetes"
}

Measured on that call: 729 ms.

Code

curl -X POST https://api.foxapis.com/v1/science/clinicaltrials/search \
  -H "Authorization: Bearer YOUR_KEY" \
  -H "Content-Type: application/json" \
  -d '{"condition":"type 2 diabetes"}'
import requests

r = requests.post(
    "https://api.foxapis.com/v1/science/clinicaltrials/search",
    headers={"Authorization": "Bearer YOUR_KEY"},
    json={"condition":"type 2 diabetes"},
)
print(r.json())
const r = await fetch("https://api.foxapis.com/v1/science/clinicaltrials/search", {
  method: "POST",
  headers: { "Authorization": "Bearer YOUR_KEY", "Content-Type": "application/json" },
  body: JSON.stringify({"condition":"type 2 diabetes"}),
});
console.log(await r.json());

n8n (HTTP Request node: paste it into a workflow)

{
  "nodes": [
    {
      "name": "ClinicalTrials.gov search",
      "type": "n8n-nodes-base.httpRequest",
      "typeVersion": 4,
      "position": [
        0,
        0
      ],
      "parameters": {
        "method": "POST",
        "url": "https://api.foxapis.com/v1/science/clinicaltrials/search",
        "sendHeaders": true,
        "headerParameters": {
          "parameters": [
            {
              "name": "Authorization",
              "value": "Bearer YOUR_KEY"
            }
          ]
        },
        "sendBody": true,
        "specifyBody": "json",
        "jsonBody": "{\"condition\":\"type 2 diabetes\"}"
      }
    }
  ],
  "connections": {}
}

Assistants (Claude, ChatGPT, Cursor)

Connect the FoxAPIs server once; the tools it offers are listed on the MCP page.

claude mcp add --transport http foxapis https://foxapis.com/mcp \
  --header "Authorization: Bearer YOUR_KEY"

Errors and limits

Free to start: 100 credits, no card. Then from $10. Credits you buy never expire.

Get my free key

Same category: Science and health · all APIs

How we calculate

Data: scripts/data/endpoint-credits.json and plans.json, 2026-11-20. Every other figure on this page is copied from the record, not calculated by us.